Stocklytics Platform
Asset logo for symbol GH
Guardant Health
GH55
$31.67arrow_drop_up1.70%$0.53
Asset logo for symbol GH
GH55

$31.67

arrow_drop_up1.70%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Guardant Health (GH) Stocklytics Forecast

Guardant Health Inc (GH) is a leading precision oncology company focused on developing groundbreaking diagnostic tests to improve cancer detection and treatment. With its innovative liquid biopsy technology, Guardant Health offers a non-invasive way to analyze tumor DNA in the blood, providing personalized and early detection of cancer. The company has experienced tremendous growth since its inception and is well-positioned to capitalize on the increasing demand for precision medicine.
The stock price of Guardant Health Inc has shown significant potential for growth in recent years, and many analysts believe it will continue to perform well in the future. With its unique technology and expanding product portfolio, GH is poised to capture a larger market share in the oncology diagnostics industry. The company has already established partnerships with major pharmaceutical companies and has a strong pipeline of new diagnostic tests in development.
add Guardant Health to watchlist

Keep an eye on Guardant Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Guardant Health (GH) stock?

Analysts have set a target price of $48.29 for Guardant Health (GH), based on forecasts from 24 analysts. The predicted price range extends from a high of $73 to a low of $27. This represents a potential increase of up to 130.5% and a decrease of -14.75% from the current price of $31.67. These forecasts are as of 2023 Jan 05.
help

What are the analyst ratings for Guardant Health (GH) stock?

The analyst ratings for Guardant Health (GH) are distributed as follows: 21 analysts recommend buying, 1 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 22 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Guardant Health .
help

What is the AI price prediction for Guardant Health (GH) stock?

At present, there is no AI or machine-learning-based price prediction available for Guardant Health (GH) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level